Trexquant Investment LP Purchases 397,962 Shares of Oscar Health, Inc. $OSCR

Key Points

• Trexquant Investment LP increased its holdings in Oscar Health, acquiring an additional 397,962 shares, bringing its total to 677,845 shares, valued at approximately $8.89 million.
• Several institutional investors are actively buying and selling shares of Oscar Health, with about 75.70% of the stock currently held by these investors.
• Analysts have recently downgraded Oscar Health’s stock ratings, with a consensus rating of "Strong Sell" and a target price of $12.07.

Trexquant Investment LP boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 142.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 677,845 shares of the company's stock after acquiring an additional 397,962 shares during the quarter. Trexquant Investment LP owned 0.27% of Oscar Health worth $8,887,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Deerfield Management Company L.P. Series C grew its holdings in Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the period. Nuveen LLC bought a new position in shares of Oscar Health in the first quarter worth about $29,684,000. Thrive Capital Management LLC boosted its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the period. Man Group plc boosted its stake in shares of Oscar Health by 344.8% in the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after acquiring an additional 1,405,554 shares during the period. Finally, Ancient Art L.P. boosted its stake in shares of Oscar Health by 66.8% in the fourth quarter. Ancient Art L.P. now owns 2,950,753 shares of the company's stock worth $39,658,000 after acquiring an additional 1,182,134 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Down 1.4%

Shares of NYSE OSCR traded down $0.23 during midday trading on Tuesday, hitting $16.44. The company's stock had a trading volume of 14,063,324 shares, compared to its average volume of 13,584,614. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The business's 50 day moving average is $15.95 and its two-hundred day moving average is $14.92. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The firm has a market cap of $4.25 billion, a P/E ratio of -20.29 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the prior year, the business posted $0.20 earnings per share. The company's revenue for the quarter was up 29.0% on a year-over-year basis. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Ratings Changes

OSCR has been the topic of a number of recent research reports. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Robert W. Baird restated a "neutral" rating and set a $14.00 price objective (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price objective for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Finally, Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Four analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.